78 results on '"Verburg, Frederik A"'
Search Results
2. Cardiovascular disease and radiopharmaceutical therapies– an underestimated risk?
3. Tubarial salivary glands show a low relative contribution to functional salivary gland tissue mass
4. Connectivity based on glucose dynamics reveals exaggerated sensorimotor network coupling on subject-level in Parkinson’s disease
5. Intra-arterial PSMA injection using hepatic arterial infusion pump in intrahepatic cholangiocarcinoma: a proof-of-concept study
6. Reduction of [68Ga]Ga-DOTA-TATE injected activity for digital PET/MR in comparison with analogue PET/CT
7. Fiat lux: the dawn of fluorescence in molecular imaging of differentiated thyroid cancer
8. The EANM guideline on radioiodine therapy of benign thyroid disease
9. Normal organ dosimetry for thyroid cancer patients treated with radioiodine as part of the multi-centre multi-national Horizon 2020 MEDIRAD project
10. Results from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetry
11. Replacing Lu-177 with Tb-161 in DOTA-TATE and PSMA-617 therapy: potential dosimetric implications for activity selection
12. Current research topics in FAPI theranostics: a bibliometric analysis
13. To give or not to give? A critical appraisal of a clinical trial on radioiodine treatment
14. Ruolo dell’imaging medico nucleare nell’iperparatiroidismo
15. EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands
16. Asinus in Tegulis—basing stark warning messages on insufficient methodology
17. The EANM practice guidelines for parathyroid imaging
18. Perioperative diagnostics of patients referred for radioiodine therapy of differentiated thyroid carcinoma: referral center experience in an iodine-insufficient country
19. Higher thyroid hormone levels and cancer
20. EANM position paper on article 56 of the Council Directive 2013/59/Euratom (basic safety standards) for nuclear medicine therapy
21. Errare humanum est, sed in errare perseverare diabolicum: methodological errors in the assessment of the relationship between I-131 therapy and possible increases in the incidence of malignancies
22. To go where no one has gone before: the necessity of radiobiology studies for exploration beyond the limits of the “Holy Gray” in radionuclide therapy
23. A dedicated paediatric [18F]FDG PET/CT dosage regimen
24. Correction to: Higher thyroid hormone levels and cancer
25. Brief progress report from the intersocietal working group on differentiated thyroid cancer
26. “Quid autem vides festucam in oculo fratris tui et trabem in oculo tuo non vide” on the hyperthyroidism-induced mortality and antithyroid drug-induced side effects in the era of radioiodine fake news
27. Positive [18F]fluoroethyltyrosine PET/MRI in suspected recurrence of growth hormone–producing pituitary adenoma in a paediatric patient
28. The limits of the “holy gray” in radioembolization and beyond: Beyond the “holy Gray”
29. Prostate specific membrane antigen (PSMA) in urothelial cell carcinoma (UCC) is associated with tumor grading and staging
30. EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma
31. Differentiated thyroid cancer patients potentially benefitting from postoperative I-131 therapy: a review of the literature of the past decade
32. Evaluation of 167 Gene Expression Classifier (GEC) and ThyroSeq v2 Diagnostic Accuracy in the Preoperative Assessment of Indeterminate Thyroid Nodules: Bivariate/HROC Meta-analysis
33. Sonographic diagnosis of thyroid cancer with support of AI
34. Intracranial hemangiopericytoma showing excellent uptake on arterial injection of [68Ga]DOTATATE
35. Postoperative serum thyroglobulin and neck ultrasound to drive decisions about iodine-131 therapy in patients with differentiated thyroid carcinoma: an evidence-based strategy?
36. No time like the present: time to re-think our habits in science and continuous medical education?
37. I-131 as adjuvant treatment for differentiated thyroid carcinoma may cause an increase in the incidence of secondary haematological malignancies: an “inconvenient” truth?
38. Radioiodine treatment after surgery for differentiated thyroid cancer: a reasonable option
39. Evaluation of 131I scintigraphy and stimulated thyroglobulin levels in the follow up of patients with DTC: a retrospective analysis of 1420 patients
40. The reconstruction algorithm used for [68Ga]PSMA-HBED-CC PET/CT reconstruction significantly influences the number of detected lymph node metastases and coeliac ganglia
41. Use of anti-thyroid drugs in patients with hyperthyroidism: a case for shared decision-making
42. A new perspective for nuclear medicine: expanding the indications for PSMA targeted imaging and therapy
43. The “reset button” revisited: why high activity 131I therapy of advanced differentiated thyroid cancer after dosimetry is advantageous for patients
44. Searching for the most effective thyrotropin (TSH) threshold to rule-out autonomously functioning thyroid nodules in iodine deficient regions
45. Detection of recurrent prostate cancer lesions before salvage lymphadenectomy is more accurate with 68Ga-PSMA-HBED-CC than with 18F-Fluoroethylcholine PET/CT
46. The 2015 Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the “evidence-based” refusal to endorse them by EANM due to the “not evidence-based” marginalization of the role of Nuclear Medicine
47. Why the European Association of Nuclear Medicine has declined to endorse the 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer
48. Extent of disease in recurrent prostate cancer determined by [68Ga]PSMA-HBED-CC PET/CT in relation to PSA levels, PSA doubling time and Gleason score
49. Endogenous TSH levels at the time of 131I ablation do not influence ablation success, recurrence-free survival or differentiated thyroid cancer-related mortality
50. Determinants of successful ablation and complete remission after total thyroidectomy and 131I therapy of paediatric differentiated thyroid cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.